Calycosin-7-O-β-D-glucoside (intraperitoneal injection; 26.8 mg/kg; 14 days) significantly reduces infarct volume, histological damage and BBB permeability in the in vivo MCAO ischemia-reperfusion rat model.
Animal Model:
Middle cerebral artery occlusion (MCAO) male adult Sprague-Daweley rats
Dosage:
26.8 mg/kg
Administration:
Intraperitoneal injection; 26.8 mg/kg; 14 days
Result:
Exhibited neuroprotective effects in rats.
体外研究
Calycosin-7-O-β-D-glucoside (2 μM; 6 hours) remarkably inhibits the expression and activities of MMPs, and secures the expression of cav-1 and tight junction proteins in the microvessels isolated from ischemic rat cortex.